ENDOCYTE INC

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$241.5M

939 transactions

Summary

ENDOCYTE INC is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $13.7MSales: $10.8M44 insiders

Date	Insider	Type	Value
2018-12-21	Low Philip S(Chief Science Officer)	D	$8.4M
2018-12-21	Low Philip S(Chief Science Officer)	D	$3.2M
2018-12-21	Andriole Michael T.(Chief Financial Officer)	D	$1.6M
2018-12-21	Andriole Michael T.(Chief Financial Officer)	D	$1.3M
2018-12-21	Low Philip S(Chief Science Officer)	D	$1.2M
2018-12-21	Low Philip S(Chief Science Officer)	D	$1.1M
2018-12-21	Andriole Michael T.(Chief Financial Officer)	D	$1.0M
2018-12-21	Low Philip S(Chief Science Officer)	D	$992K
2018-12-21	Low Philip S(Chief Science Officer)	D	$945K
2018-12-21	Andriole Michael T.(Chief Financial Officer)	D	$900K
2018-12-21	Andriole Michael T.(Chief Financial Officer)	D	$900K
2018-12-21	Low Philip S(Chief Science Officer)	D	$805K
2018-12-21	Low Philip S(Chief Science Officer)	D	$764K
2018-12-21	Andriole Michael T.(Chief Financial Officer)	D	$600K
2018-12-21	Low Philip S(Chief Science Officer)	D	$464K
2018-12-21	Low Philip S(Chief Science Officer)	D	$315K
2018-12-21	Low Philip S(Chief Science Officer)	D	$274K
2018-12-21	Low Philip S(Chief Science Officer)	D	$219K
2018-12-21	Low Philip S(Chief Science Officer)	D	$128K
2018-12-21	Low Philip S(Chief Science Officer)	D	$105K

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

ENDOCYTE INC — Contributions, Lobbying & Contracts | Poliscope